León-Mengíbar, J, Bermúdez-López, M, Valdivielso, JM, Pamplona, R, Torres, G, Mauricio, D, Castro-Boqué, E, Fernández, E, Caixàs, A, Bueno, M, Ciudin, A, Hernández, M, Simó, R, Hernández, C, Lecube, A. Impact of the new EASO obesity definition on the detection of atheromatosis in subjects with low-to-moderate cardiovascular risk. Frontiers in Endocrinology. 2025; 16DOI:10.3389/fendo.2025.1689960. PMID:41141356. IF:4.600(Q1/3D).

Ma, CX, Ma, XN, Liu, JJ, Guan, CH, Li, YD, Zhao, N, Mauricio, D, Fu, SB. The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia (vol581, 112113, 2024). MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2025; 608DOI:10.1016/j.mce.2025.112626. PMID:40750504. IF:3.600(Q2/4D).

Ma, CX, Ma, XN, Li, HL, Mauricio, D, Fu, SB. Endocrine-disrupting chemicals exposure: cardiometabolic health risk in humans. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02938-8. PMID:41035032. IF:10.600(Q1/1D).

Alarcón, PP, Alvarez, ED, Goitia, CL, Rodríguez, MM, Urbon, L, Maldonado, A, García, S, Serrallonga, NB, Aviño, LR, Palomar, JMR, Lopez, JG, Hoyas, CIN, Corcoy, R, Raimond, TM, López, ML, Madorell, BS, Hernández, M, Kyriakos, G, Bellas, LC, Borrás, JG, Servant, OS, Colet, AM, Serrano, C, Contreras, C, Román, AR, Díez, M, Veladesojo, A, Andujar, P, Diez, A, Galiana, PA, Peris, BP, Fernandez, E, Ferrer, M, Alfonso, FJG, Torre, ELM. Does Combining a Mobile Dose Calculation App with a Continuous Insulin Infusion System Improve Glycemic Control and Quality of Life Compared with a Hybrid System in Patients with Type 1 Diabetes? A Descriptive Open-Label Sequential Study. Diabetes Technology & Therapeutics. 2025; 27(10)DOI:10.1177/15209156251363452. PMID:40729095. IF:6.300(Q1/2D).

Martin, FJES, Lesmes, IB, Peralta, FG, Torres, JFM, Gómez, FP, Ballesteros, AC, González-Clemente, JM, de Villar, NGP, Portillo, CM, Corrales, PJP, Engel, WR, de Inestrosa, MTBP, Fernández-Santos, CM, Arranz, E, Vinagre, GF, Perán, JF, Sedisa, Brocca, MAM. Executive summary of the document 'Diabetes Day Hospital. Value proposition'. Endocrinologia Diabetes y Nutricion. 2025; 72(8)DOI:10.1016/j.endien.2025.501601. PMID:40946027. IF:1.800(Q3/8D).

Puig, R, Rojo-López, MI, Julve, J, Castelblanco, E, Ponomarenko, J, Amezqueta, S, Vendrell, J, Franch-Nadal, J, Torres, JL, Mauricio, D, Ramos-Romero, S. Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional Study. Nutrients. 2025; 17(18)DOI:10.3390/nu17183003. PMID:41010528. IF:5.000(Q1/2D).

Milad, C, Viñals, C, Perea, V, Seres-Noriega, T, Blanco-Carrasco, A, Vinagre, I, Claro, M, Solà, C, Mesa, A, Ayala, D, Conget, I, Gimenez, M, Amor, AJ. Adherence to Modified American Heart Association Cardiovascular Health Standards Is Associated With Lower Atherosclerotic Burden in Mediterranean Individuals With Type 1 Diabetes. DIABETES-METABOLISM RESEARCH AND REVIEWS. 2025; 41(6)DOI:10.1002/dmrr.70088. PMID:40965235. IF:6.000(Q1/2D).

Páez-Espinosa, EV, Sosa-Guzmán, DM, Buitrón-Andrade, LR, Dávila-Jumbo, N, Cáceres-Ruiz, MI, Robalino-Flores, VF, Mato-Matute, E. Morbidity and Mortality Profile of Leishmaniasis in an Andean Region of Ecuador in the Context of Climate Change. Tropical Medicine and Infectious Disease. 2025; 10(9)DOI:10.3390/tropicalmed10090254. PMID:41003564. IF:2.600(Q1/1D).

Voss, EA, Yuan, Z, Ali, SR, Bosan, R, Eworuke, E, Brewster, J, Vlacho, B, Fernández-Camins, B, Fernández-Bertolín, S, Fonseca, S, Jeffcoat, C, Wang, L. A study on the utilization of canagliflozin in type 1 diabetes mellitus using real-world data from four European countries. DIABETES OBESITY & METABOLISM. 2025; 27(9)DOI:10.1111/dom.16574. PMID:40605139. IF:5.700(Q1/2D).

Wyckoff, JA, Lapolla, A, Asias-Dinh, BD, Barbour, LA, Brown, FM, Catalano, PM, Corcoy, R, Di Renzo, GC, Drobycki, N, Kautzky-Willer, A, Murad, MH, Stephenson-Gray, M, Tabák, AG, Weatherup, E, Zera, C, Singh-Ospina, N. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(9)DOI:10.1210/clinem/dgaf288. PMID:40652453. IF:5.100(Q1/2D).

Viñals, C, Conget, I, Granados, M, Solà, C, Ayala, D, Mesa, A, Seres-Noriega, T, Domenech, M, Perea, V, Blanco, J, Vinagre, I, Gimenez, M, Amor, AJ. Factors Involved in the Progression of Preclinical Atherosclerosis in People with Type 1 Diabetes. Journal of Clinical Medicine. 2025; 14(17)DOI:10.3390/jcm14176004. PMID:40943764. IF:2.900(Q1/2D).

Claro, M, Viñals, C, Giménez, M, Perea, V, Granados, M, Serés-Noriega, T, Blanco, J, Vinagre, I, Mesa, A, Milad, C, Ayala, D, Solà, C, Esmatjes, E, Conget, I, Amor, AJ. Hepatic steatosis with significant fibrosis is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 226DOI:10.1016/j.diabres.2025.112334. PMID:40543571. IF:7.400(Q1/1D).

Karagiannis, T, Advani, A, Davies, MJ, Del Prato, S, Dinneen, SF, Kuss, O, Lorenzoni, V, Mathieu, C, Mauricio, D, Tankova, T, Zaccardi, F, Holt, RIG, Tsapas, A, EASD Guidelines Oversight Comm. European Association for the Study of Diabetes (EASD) Standard Operating Procedure for the development of guidelines. DIABETOLOGIA. 2025; 68(8)DOI:10.1007/s00125-025-06370-1. PMID:40447848. IF:10.200(Q1/1D).

Chico, A, Pazos-Couselo, M, Nattero-Chavez, L, Simó-Servat, O, Durán-Martínez, M, Ugarte-Abasolo, E, Aguilera, E, Andía, V, Moreno-Fernández, J, Granados, M, Rebollo, A, Fernandez-Rubio, E, Quirós, C, Alpañés, M, Márquez, R, Beato-Vibora, P, Lado-Baleato, O, Picón-César, M. Beyond glycemic metrics: Real-world benefits of connected insulin pens in type 1 diabetes. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 226DOI:10.1016/j.diabres.2025.112377. PMID:40695413. IF:7.400(Q1/1D).

Almendra-Pegueros, R, Barros-Membrilla, A, Perez-Marlasca, E, Tabilo-Ahumada, J, Julve, J, Sanchez-Quesada, JL, Medina-Gómez, G, Martínez-González, JE, Rodríguez, C, Galán, M. Mitochondrial dysfunction and endoplasmic reticulum stress in atherosclerotic degenerative ascending aortic aneurysm: A transcriptomic analysis. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).

Merino, M, Maravilla-Herrera, P, Artola, S, Escalada, J, Pérez, A, Remón, J, Trillo-Mata, JL, Vallès-Callol, JA, Hidalgo-Vega, A. Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain: quantifying the social value. Frontiers in Public Health. 2025; 13DOI:10.3389/fpubh.2025.1511108. PMID:40717941. IF:3.400(Q1/2D).

Sardà, H, Genua, I, Miñambres, I. GLP-1 receptor agonists in obesity treatment: Effects on cardiometabolic variables and cardiovascular disease. MEDICINA CLINICA. 2025; 165(1)DOI:10.1016/j.medcli.2025.106951. PMID:40378625. IF:2.100(Q2/3D).

Almendra-Pegueros, R, Barros-Membrilla, AJ, Pérez-Marlasca, E, Julve, J, Martinez-González, J, Rodriguez, C, Galán, M. Identification of new therapeutic targets related to endoplasmic reticulum stress and mitochondrial dysfunction to reduce the risk of rupture in degenerative ascending aortic aneurysm. Clinica E Investigacion En Arteriosclerosis. 2025; 37(4)DOI:10.1016/j.arteri.2024.09.002. PMID:39424523. IF:(Q/D).

Wyckoff, JA, Lapolla, A, Asias-Dinh, BD, Barbour, LA, Brown, FM, Catalano, PM, Corcoy, R, Di Renzo, GC, Drobycki, N, Kautzky-Willer, A, Murad, MH, Stephenson-Gray, M, Tabák, AG, Weatherup, E, Zera, C, Singh-Ospina, N. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2025; 193(1)DOI:10.1093/ejendo/lvaf116. PMID:40652450. IF:5.200(Q1/2D).

Lazarus, JV, Wajcman, DI, Pannain, S, Brennan, PN, Manolas, MI, Jepsen, P, Treloar, C, Arora, AK, Matthews, PC, Picchio, CA, White, TM, Grebely, J, Vaz, J, Hagström, H, Rabin, KH, Isaacs, S, Ribeiro, RT, Roden, M, Betel, M, Willemse, J, Díaz, LA, Allen, AM, Alkhouri, N, Schattenberg, JM, Mauricio, D, Rinella, ME, Pose, E, Tsochatzis, EA, Ninburg, M, Cusi, K, Alazawi, W, Duseja, A, Frühbeck, G, Lofton, H, Jaisinghani, P, Kanwal, F, Shiha, G, Zelber-Sagi, S, Holden, L, Villota-Rivas, M. The People-First Liver Charter. NATURE MEDICINE. 2025; 31(7)DOI:10.1038/s41591-025-03759-8. PMID:40473951. IF:50.000(Q1/1D).